Overuse or underuse of methylphenidate in adults in France: commentary on Pauly et al. 2018
Br J Clin Pharmacol. 2018-09-25; 85(1): 273-274
DOI: 10.1111/bcp.13758
Lire sur PubMed
Weibel S(1)(2), Lopez R(3)(4), Micoulaud-Franchi JA(5)(6), Bioulac S(5)(6), Lecendreux M(7)(8), Bertschy G(1)(2).
Author information:
(1)Department of Psychiatry, University Hospital of Strasbourg, Strasbourg, France.
(2)Inserm 1114, Federation of Translational Medicine of Strasbourg (FMTS), Strasbourg, France.
(3)National Reference Network for Narcolepsy, Sleep-Wake Disorders Center, Department of Neurology, Gui-de-Chauliac Hospital, Montpellier, France.
(4)INSERM, University of Montpellier, Neuropsychiatry: Epidemiological and Clinical Research, Montpellier, France.
(5)Bordeaux Sleep Clinic, Pellegrin University Hospital, 33 076, Bordeaux, France.
(6)Bordeaux University, USR CNRS 3413 SANPSY Research Unit, Bordeaux, France.
(7)AP-HP, Pediatric Sleep Center, Robert-Debré Hospital, Paris, France.
(8)National Reference Network for Narcolepsy, Paris, France.
Comment in
Br J Clin Pharmacol. 2019 Jan;85(1):275-276.
Comment on
Br J Clin Pharmacol. 2018 Jun;84(6):1215-1227.